CEBPA and lung adenocarcinoma: Previous studies have demonstrated decreased or absent of C/EBPα expression in 50% of stage II and IIIA lung adenocarcinomas, suggesting that C/EBPα may function as a tumor suppressor in the lung [10]–[12].